
Opinion|Videos|February 4, 2025
New Horizons in NMIBC: Pipeline Innovations and Clinical Perspectives
Experts discuss current trial data from several studies on non-muscle invasive bladder cancer (NMIBC).
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5











